The services and products of Systasy Bioscience GmbH from Munich aim to reduce the costs of development processes in pharmaceutical and biomedical research by accelerating drug development. For example, the EXTassay and splitSENSOR technologies allow simultaneous monitoring of multiple cellular signal transduction events. This can generate large meaningful data sets that can be used in the network for modeling and optimizing drug properties.